HeartWare Sees Q4 Sales ~$32M
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects total revenues for the fourth quarter of 2012 will be approximately $32 million, bringing expected full-year 2012 revenues to approximately $110 million.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.